Latest Global Pharma News News
Latest News : Lupin received approval to market a generic equivalent of Multaq Tablets- Dronedarone Tablets US
Latest News : Lupin received approval to market…
Glenmark signed license agreement for further developing, registering, and commercializing Envafolimab in India, Asia Pacific
Glenmark signed license agreement for further developing, registering,…
Glenmark is the first to launch Biosimilar of Popular Anti‐Diabetic Drug,
Liraglutide, in India
‐ The anti‐diabetic biosimilar has been launched under…
Biological E. Limited’s (BE) Injectable Facility at Shamirpet has received an EIR from USFDA!
Biological E. Limited’s (BE) Injectable Facility at Shamirpet…
Syngene was awarded the “Golden Peacock National Quality Award 2023”
We are happy to share that Syngene was…
Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets
Lupin received tentative approval from the United States Food…
Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%
Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and…
Top Pharma News Updates- Glenmark, Lupin, Intas Pharma, Amneal Pharma & Biological E. Limited (BE)
Top Pharma News Updates- Glenmark, Lupin, Intas Pharma,…
BE TO GET mRNA TECH FROM WHO TO PRODUCE COVID-19 VACCINES
WHO selects BE as a recipient of mRNA…
Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar in the Middle East
Intas and Axantia sign an exclusive agreement for…
